Cargando…
WT1 Expression Levels Combined with Flow Cytometry Blast Counts for Risk Stratification of Acute Myeloid Leukemia and Myelodysplastic Syndromes
Wilm’s tumor 1 (WT1), a zinc-finger transcription factor and an epigenetic modifier, is frequently overexpressed in several hematologic disorders and solid tumors, and it has been proposed as diagnostic and prognostic marker of acute myeloid leukemia (AML) and myelodysplastic syndrome (MDS). However...
Autores principales: | , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8067344/ https://www.ncbi.nlm.nih.gov/pubmed/33917307 http://dx.doi.org/10.3390/biomedicines9040387 |
_version_ | 1783682781104046080 |
---|---|
author | Giudice, Valentina Gorrese, Marisa Vitolo, Rosa Bertolini, Angela Marcucci, Rossella Serio, Bianca Guariglia, Roberto Ferrara, Idalucia Pepe, Rita D’Alto, Francesca Izzo, Barbara Pedicini, Antonio Montuori, Nunzia Langella, Maddalena Selleri, Carmine |
author_facet | Giudice, Valentina Gorrese, Marisa Vitolo, Rosa Bertolini, Angela Marcucci, Rossella Serio, Bianca Guariglia, Roberto Ferrara, Idalucia Pepe, Rita D’Alto, Francesca Izzo, Barbara Pedicini, Antonio Montuori, Nunzia Langella, Maddalena Selleri, Carmine |
author_sort | Giudice, Valentina |
collection | PubMed |
description | Wilm’s tumor 1 (WT1), a zinc-finger transcription factor and an epigenetic modifier, is frequently overexpressed in several hematologic disorders and solid tumors, and it has been proposed as diagnostic and prognostic marker of acute myeloid leukemia (AML) and myelodysplastic syndrome (MDS). However, the exact role of WT1 in leukemogenesis and disease progression remains unclear. In this real-world evidence retrospective study, we investigated prognostic role of WT1-mRNA expression levels in AML and MDS patients and correlations with complete blood counts, flow cytometry counts, and molecular features. A total of 71 patients (AML, n = 46; and MDS, n = 25) were included in this study, and WT1 levels were assessed at diagnosis, during treatment and follow-up. We showed that WT1 expression levels were inversely correlated with normal hemopoiesis in both AML and MDS, and positively associated with blast counts. Flow cytometry was more sensitive and specific in distinguishing normal myeloid cells from neoplastic counterpart even just using linear parameters and CD45 expression. Moreover, we showed that a simple integrated approach combining blast counts by flow cytometry, FLT3 mutational status, and WT1 expression levels might be a useful tool for a better prognostic definition in both AML and MDS patients. |
format | Online Article Text |
id | pubmed-8067344 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-80673442021-04-25 WT1 Expression Levels Combined with Flow Cytometry Blast Counts for Risk Stratification of Acute Myeloid Leukemia and Myelodysplastic Syndromes Giudice, Valentina Gorrese, Marisa Vitolo, Rosa Bertolini, Angela Marcucci, Rossella Serio, Bianca Guariglia, Roberto Ferrara, Idalucia Pepe, Rita D’Alto, Francesca Izzo, Barbara Pedicini, Antonio Montuori, Nunzia Langella, Maddalena Selleri, Carmine Biomedicines Article Wilm’s tumor 1 (WT1), a zinc-finger transcription factor and an epigenetic modifier, is frequently overexpressed in several hematologic disorders and solid tumors, and it has been proposed as diagnostic and prognostic marker of acute myeloid leukemia (AML) and myelodysplastic syndrome (MDS). However, the exact role of WT1 in leukemogenesis and disease progression remains unclear. In this real-world evidence retrospective study, we investigated prognostic role of WT1-mRNA expression levels in AML and MDS patients and correlations with complete blood counts, flow cytometry counts, and molecular features. A total of 71 patients (AML, n = 46; and MDS, n = 25) were included in this study, and WT1 levels were assessed at diagnosis, during treatment and follow-up. We showed that WT1 expression levels were inversely correlated with normal hemopoiesis in both AML and MDS, and positively associated with blast counts. Flow cytometry was more sensitive and specific in distinguishing normal myeloid cells from neoplastic counterpart even just using linear parameters and CD45 expression. Moreover, we showed that a simple integrated approach combining blast counts by flow cytometry, FLT3 mutational status, and WT1 expression levels might be a useful tool for a better prognostic definition in both AML and MDS patients. MDPI 2021-04-06 /pmc/articles/PMC8067344/ /pubmed/33917307 http://dx.doi.org/10.3390/biomedicines9040387 Text en © 2021 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Giudice, Valentina Gorrese, Marisa Vitolo, Rosa Bertolini, Angela Marcucci, Rossella Serio, Bianca Guariglia, Roberto Ferrara, Idalucia Pepe, Rita D’Alto, Francesca Izzo, Barbara Pedicini, Antonio Montuori, Nunzia Langella, Maddalena Selleri, Carmine WT1 Expression Levels Combined with Flow Cytometry Blast Counts for Risk Stratification of Acute Myeloid Leukemia and Myelodysplastic Syndromes |
title | WT1 Expression Levels Combined with Flow Cytometry Blast Counts for Risk Stratification of Acute Myeloid Leukemia and Myelodysplastic Syndromes |
title_full | WT1 Expression Levels Combined with Flow Cytometry Blast Counts for Risk Stratification of Acute Myeloid Leukemia and Myelodysplastic Syndromes |
title_fullStr | WT1 Expression Levels Combined with Flow Cytometry Blast Counts for Risk Stratification of Acute Myeloid Leukemia and Myelodysplastic Syndromes |
title_full_unstemmed | WT1 Expression Levels Combined with Flow Cytometry Blast Counts for Risk Stratification of Acute Myeloid Leukemia and Myelodysplastic Syndromes |
title_short | WT1 Expression Levels Combined with Flow Cytometry Blast Counts for Risk Stratification of Acute Myeloid Leukemia and Myelodysplastic Syndromes |
title_sort | wt1 expression levels combined with flow cytometry blast counts for risk stratification of acute myeloid leukemia and myelodysplastic syndromes |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8067344/ https://www.ncbi.nlm.nih.gov/pubmed/33917307 http://dx.doi.org/10.3390/biomedicines9040387 |
work_keys_str_mv | AT giudicevalentina wt1expressionlevelscombinedwithflowcytometryblastcountsforriskstratificationofacutemyeloidleukemiaandmyelodysplasticsyndromes AT gorresemarisa wt1expressionlevelscombinedwithflowcytometryblastcountsforriskstratificationofacutemyeloidleukemiaandmyelodysplasticsyndromes AT vitolorosa wt1expressionlevelscombinedwithflowcytometryblastcountsforriskstratificationofacutemyeloidleukemiaandmyelodysplasticsyndromes AT bertoliniangela wt1expressionlevelscombinedwithflowcytometryblastcountsforriskstratificationofacutemyeloidleukemiaandmyelodysplasticsyndromes AT marcuccirossella wt1expressionlevelscombinedwithflowcytometryblastcountsforriskstratificationofacutemyeloidleukemiaandmyelodysplasticsyndromes AT seriobianca wt1expressionlevelscombinedwithflowcytometryblastcountsforriskstratificationofacutemyeloidleukemiaandmyelodysplasticsyndromes AT guarigliaroberto wt1expressionlevelscombinedwithflowcytometryblastcountsforriskstratificationofacutemyeloidleukemiaandmyelodysplasticsyndromes AT ferraraidalucia wt1expressionlevelscombinedwithflowcytometryblastcountsforriskstratificationofacutemyeloidleukemiaandmyelodysplasticsyndromes AT peperita wt1expressionlevelscombinedwithflowcytometryblastcountsforriskstratificationofacutemyeloidleukemiaandmyelodysplasticsyndromes AT daltofrancesca wt1expressionlevelscombinedwithflowcytometryblastcountsforriskstratificationofacutemyeloidleukemiaandmyelodysplasticsyndromes AT izzobarbara wt1expressionlevelscombinedwithflowcytometryblastcountsforriskstratificationofacutemyeloidleukemiaandmyelodysplasticsyndromes AT pediciniantonio wt1expressionlevelscombinedwithflowcytometryblastcountsforriskstratificationofacutemyeloidleukemiaandmyelodysplasticsyndromes AT montuorinunzia wt1expressionlevelscombinedwithflowcytometryblastcountsforriskstratificationofacutemyeloidleukemiaandmyelodysplasticsyndromes AT langellamaddalena wt1expressionlevelscombinedwithflowcytometryblastcountsforriskstratificationofacutemyeloidleukemiaandmyelodysplasticsyndromes AT sellericarmine wt1expressionlevelscombinedwithflowcytometryblastcountsforriskstratificationofacutemyeloidleukemiaandmyelodysplasticsyndromes |